{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-037360","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2026-08-12T20:15:20+00:00","discovered_at":"2026-08-12T20:16:01.785454+00:00","generated_at":"2026-08-12T20:16:10.760446+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Interpace Q2 2026: revenue $9.1M, income $0.3M vs prior loss; thyroid revenue +9% YoY","bullets":["Q2 revenue $9.1M, up 9% Pro Forma (ex-PancraGEN); income from continuing ops $0.3M vs $0.5M loss prior year.","Thyroid revenue +9% YoY, volume +6%; TTM thyroid revenue $36.1M, up 11%; gross margin 62% vs 54% Pro Forma.","Adjusted EBITDA $0.7M (8% margin) vs $0.2M Pro Forma prior year; includes $0.2M one-time strategic fees.","H1 2026 income $1.1M vs $0.2M loss Pro Forma; Adjusted EBITDA $2.3M (13% margin); debt-free balance sheet.","Adding Chief Scientific Officer Sept 8, 2026; pancreatic cancer program in development, no revenue expected in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-037360","json":"https://secwatch.observer/filing/0001493152-26-037360.json","markdown":"https://secwatch.observer/filing/0001493152-26-037360.md","text":"https://secwatch.observer/filing/0001493152-26-037360.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226037360/0001493152-26-037360-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226037360/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T20:16:10.760446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}